Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

This study has been completed.
Sponsor:
Information provided by:
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00250809
First received: November 4, 2005
Last updated: January 6, 2010
Last verified: March 2009
  Purpose

CVC Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study


Condition Intervention
Other Female Genital
Cancer
Procedure: Placement of a central venous catheter

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: CVC Pros and Cons of Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

Further study details as provided by University of New Mexico:

Primary Outcome Measures:
  • Pros and Cons of scheduled Triple-lumen Central Venous Catheter Exchange [ Time Frame: 3 years ] [ Designated as safety issue: Yes ]

Enrollment: 15
Study Start Date: March 1994
Study Completion Date: March 2006
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Placement of a central venous catheter
    Placement of a central venous catheter
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

1. Patients who require the placement of a central venous catheter for medical purposes and have an absence of infection.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00250809

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico
  More Information

No publications provided

Responsible Party: Harriet Smith, MD; Principal Investigator, University of New Mexico - CRTC
ClinicalTrials.gov Identifier: NCT00250809     History of Changes
Other Study ID Numbers: CVC
Study First Received: November 4, 2005
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on August 28, 2014